$VREX

Varex Imaging Corp

alphai earnings readThird quarter fiscal year 2026 · AUG 10Varex announces financial results for third quarter fiscal year 2026Verdict: solid

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

No enriched coverage for $VREX in the last 7 days.

No SEC Form 4 filings for $VREX in the last 30 days.

See all $VREX insider activity →
High

Teledyne to Acquire Varex Imaging in $1.1 Billion Deal – Metrology and Quality News

Teledyne Technologies (TDY) will acquire Varex Imaging (VREX) for $1.1 billion, including net debt and equity awards. The deal, approved by both boards, is expected to close in early 2027. Varex's X-ray technologies complement Teledyne's offerings, with minimal product overlap. The acquisition aims to accelerate Varex's product development and adoption.

Los Angeles Business Journal

Teledyne Technologies (TDY) agreed to acquire Varex Imaging (VREX) for $1.1B, or $18.90 per share in cash. The deal is expected to close in 2027. Varex's X-ray imaging tech complements Teledyne's portfolio, according to Varex's CEO. Teledyne has previously acquired firms in the healthcare sector, including Dalsa Corp. and DD-Scientific.

VREX sentiment & insider activity

Recent VREX coverage spans mergers & acquisitions, market movers and financial news.

What's driving VREX

alphai scores every news story that mentions VREX with an AI model for sentiment and relevance, and aggregates insider trades from Varex Imaging Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $VREX

Score
$TDYHighAI 9/10

Los Angeles Business Journal

Teledyne Technologies (TDY) agreed to acquire Varex Imaging (VREX) for $1.1B, or $18.90 per share in cash. The deal is expected to close in 2027. Varex's X-ray imaging tech complements Teledyne's portfolio, according to Varex's CEO. Teledyne has previously acquired firms in the healthcare sector, including Dalsa Corp. and DD-Scientific.

$LNTHMed

Weekly Buzz: LNTH, CBLL Win FDA Nod; AURA Cuts Jobs; TDY Buys VREX; CGEM, DFTX Meet Trial Goals

Biopharma roundup reported FDA/EC approvals and trial updates for Lantheus (LNTH) TAUKLARIFY, Ceribell (CBLL) AI EEG algorithms, Labcorp (LH) PGDx CDx, and EU/UK approvals for Galderma (GDERF) Restylane Shaype and Rhythm (RYTM) IMCIVREE. GRAIL (GRAL) faces an FDA panel on Sept. 23. Teledyne (TDY) to buy Varex (VREX) for about $1.1B; Aura (AURA) cut 20% staff.

$TDYMedAI 9/10

Why Is Teledyne Technologies (TDY) Paying a 52% Premium for Varex (VREX)?

Teledyne Technologies (NYSE:TDY) agreed to acquire Varex Imaging (NASDAQ:VREX) for $18.90 per share in cash, a 52% premium to Varex’s unaffected close. The deal values Varex at about $1.1 billion including equity awards and net debt. Varex jumped 48.5% to $18.42 on Aug. 10; TDY fell slightly. Teledyne cited synergies but did not quantify EPS accretion.

$TDYHighAI 10/10

Teledyne to Acquire Varex Imaging Corporation

Teledyne Technologies agreed to acquire Varex Imaging in a cash deal for $18.90 per Varex share, valuing the transaction at about $1.1 billion including equity awards and net debt as of April 3, 2026. Boards approved unanimously. Closing is expected in early 2027, pending regulatory and Varex stockholder approvals.

$VREXHighAI 10/10

Five Months After a $490 Million Refinancing, Utah’s Varex Imaging Agrees to be Acquired by Teledyne in a $1.1 Billion Deal

Varex Imaging (NASDAQ:VREX) agreed to be acquired by Teledyne Technologies (NYSE:TDY) for $18.90 per share in a cash deal valued at about $1.1 billion, including Varex equity awards and net debt. Boards approved; close expected early 2027 after shareholder and regulatory approvals. Varex completed a $490 million refinancing in March 2026.

Varex Imaging Corporation revenues hit USD 211M in Q3FY26

Varex Imaging reported unaudited Q3 FY2026 results: revenue of $211 million, GAAP gross margin 36% (non-GAAP 37%), GAAP operating margin 11% (non-GAAP 12%), and GAAP diluted EPS $0.37 (non-GAAP $0.31). Third-quarter revenues rose 4% YoY, with Medical $134 million and Industrial $77 million. The company received $17 million in U.S. Customs refunds tied to IEEPA tariffs.

$ARMMed

Stocks Finish Lower as Soaring Crude Prices Spur Inflation Fears

WTI crude oil (CLU26) jumped over 5% as Iran and Oman stayed short of a deal to reopen the Strait of Hormuz, with Iran linking reopening to US sanctions, force withdrawal, asset release and compensation. Trump said he would seek compensation from Iran. US rate-hike odds rose; stocks fell, with energy up and airlines, homebuilders down.

$DDOGMed

Stocks Mixed as Higher Crude Prices Boost T-Note Yields

US stocks were mixed as higher WTI crude pushed up Treasury yields. The 10-year T-note yield rose to 4.690% and was pressured by inflation expectations and a $125B Treasury auction. Markets priced a 47% chance of a +25 bp Fed hike and an 87% chance of an ECB hike. Company movers included DDOG, PLTR, APA, HAL, and VREX after a $1.1B acquisition.

Related tickers